AtriCure, Inc. Common Stock (NASDAQ: ATRC) last traded at $56.87, down 0.72% on the session. The quote above updates while this page is open; the figures below are drawn from AtriCure, Inc. Common Stock’s own filings and are restated only when a new one is published.
AtriCure, Inc. Common Stock trades on NASDAQ under the ticker ATRC. Its market capitalisation is $2.89 billion.
Valuation measures for AtriCure, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.89B |
|---|---|
| Enterprise value | $2.89B |
| P/E ratio | 270.81 |
| Price / sales | 5.08 |
| Price / book | 5.60 |
| Beta | 0.50 |
Trailing-twelve-month figures tagged in AtriCure, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $569.62M |
|---|---|
| Net income (TTM) | $10.55M |
| EPS (TTM) | $0.210 |
| Gross margin | 76.30% |
| Operating margin | 2.26% |
| Return on equity | 2.04% |
| Cash | $167.79M |
Range and volume for ATRC over the past 52 weeks.
| 52-week high | $61.70 |
|---|---|
| 52-week low | $25.36 |
| Volume | 596.1K |
| Average volume | 1.08M |
| Previous close | $57.28 |
Invest a chosen dollar amount in AtriCure, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ATRC.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.